JohnPaulChristodouleasMD
Radiation Oncology • Philadelphia, PAAssistant Professor, Radiation Oncology, Perelman School of Medicine
Dr. Christodouleas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Boulevard
Philadelphia, PA 19104Phone+1 215-662-6568
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2005 - 2009
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 2004 - 2005
Tufts University School of MedicineClass of 2004
Certifications & Licensure
NJ State Medical License 2009 - 2025
PA State Medical License 2009 - 2024- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer Start of enrollment: 2012 Jan 01
- Proton Therapy for High Risk Prostate Cancer Start of enrollment: 2013 Mar 01
- Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts Start of enrollment: 2014 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsRadiomics-guided therapy for bladder cancer: Using an optimal biomarker approach to determine extent of bladder cancer invasion from t2-weighted magnetic resonance imagesYubing Tong, Jayaram K. Udupa, Chuang Wang, Jerry Chen, Sriram Venigalla
Advances in Radiation Oncology. 2018-05-08 - 10 citationsFirst-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis.Ravi B. Parikh, Emily Feld, Matthew D. Galsky, Blythe Js Adamson, Aaron B Cohen
Future Oncology. 2020-01-01 - 42 citationsInitial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b...Brigid A. McDonald, Sastry Vedam, Jinzhong Yang, Jihong Wang, P. Castillo
International Journal of Radiation Oncology, Biology, Physics. 2021-04-01
Press Mentions
Award-Winning Abstracts Confirm Benefits of Elekta Unity in Precision Radiation TherapyOctober 29th, 2021- Elekta Radiotherapy System Designed for Changing Cancer Landscape Now Available for U.S. PatientsJune 17th, 2021
Crossing the Finish LineDecember 3rd, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
